ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 55 filers reported holding ESSA PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,602,911 | +4.6% | 842,366 | -8.6% | 0.06% | +22.2% |
| Q2 2023 | $2,489,238 | -30.1% | 921,940 | -23.1% | 0.04% | -35.7% |
| Q1 2023 | $3,559,061 | +286.6% | 1,198,337 | +228.0% | 0.07% | +288.9% |
| Q4 2022 | $920,556 | -21.1% | 365,300 | -43.0% | 0.02% | -18.2% |
| Q3 2022 | $1,166,000 | -78.8% | 640,645 | +39.1% | 0.02% | -54.2% |
| Q4 2020 | $5,494,000 | -32.4% | 460,500 | -60.9% | 0.05% | -52.9% |
| Q3 2020 | $8,125,000 | -11.0% | 1,177,483 | -20.0% | 0.10% | -20.3% |
| Q2 2020 | $9,125,000 | +55.0% | 1,471,853 | 0.0% | 0.13% | +29.3% |
| Q1 2020 | $5,887,000 | -27.3% | 1,471,853 | 0.0% | 0.10% | -14.7% |
| Q4 2019 | $8,095,000 | +63.2% | 1,471,853 | 0.0% | 0.12% | +23.4% |
| Q3 2019 | $4,960,000 | – | 1,471,853 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |